Charles Schwab’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-178,952
| Closed | -$4.31M | – | 3746 |
|
|
2023
Q1 | $4.31M | Buy |
178,952
+2,488
| +1% | +$60K | ﹤0.01% | 2275 |
|
|
2022
Q4 | $1.87M | Buy |
176,464
+11,358
| +7% | +$120K | ﹤0.01% | 2591 |
|
|
2022
Q3 | $743K | Buy |
165,106
+21,098
| +15% | +$94.9K | ﹤0.01% | 2888 |
|
|
2022
Q2 | $577K | Sell |
144,008
-2,055
| -1% | -$8.23K | ﹤0.01% | 3019 |
|
|
2022
Q1 | $1.07M | Buy |
146,063
+2,537
| +2% | +$18.6K | ﹤0.01% | 2823 |
|
|
2021
Q4 | $807K | Buy |
143,526
+5,168
| +4% | +$29.1K | ﹤0.01% | 2988 |
|
|
2021
Q3 | $886K | Sell |
138,358
-236,596
| -63% | -$1.52M | ﹤0.01% | 2917 |
|
|
2021
Q2 | $3.16M | Buy |
374,954
+10,925
| +3% | +$92.1K | ﹤0.01% | 2568 |
|
|
2021
Q1 | $3.82M | Buy |
364,029
+47,233
| +15% | +$496K | ﹤0.01% | 2424 |
|
|
2020
Q4 | $5.37M | Buy |
316,796
+2,256
| +0.7% | +$38.2K | ﹤0.01% | 2182 |
|
|
2020
Q3 | $4.04M | Buy |
314,540
+212,320
| +208% | +$2.72M | ﹤0.01% | 2177 |
|
|
2020
Q2 | $1.44M | Buy |
102,220
+87,667
| +602% | +$1.24M | ﹤0.01% | 2528 |
|
|
2020
Q1 | $134K | Hold |
14,553
| – | – | ﹤0.01% | 3077 |
|
|
2019
Q4 | $217K | Buy |
+14,553
| New | +$217K | ﹤0.01% | 3027 |
|